
Carmen Bergom, MD, PhD
Identification of new targets to improve tumor radiation effectiveness and to protect normal tissues such as the heart from radiation injury
- Email: acbergom@wustl.edu

Kelly L. Bolton, PhD, MD
The interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis
- Email: bolton@wustl.edu

Jian Campian, MD, PhD
Immunotherapy, brain tumor, spinal cord tumor, high grade gliomas
- Email: jcampian@dom.wustl.edu

Jaebok Choi, PhD
Understanding T cells and immunoregulatory networks in GvHD and GvL for the treatment of hematopoietic malignancies
- Email: jchoi25@wustl.edu

Francesca Ferraro, MD, PhD
We use both mouse models and patient samples of acute myloid leukemia to understand leukemogenesis and to identify novel therapeutic targets.
- Email: ferrarof@wustl.edu

Matthew Goodwin, MD, PhD
Metabolism of cancer, targeting tumor metabolism by blocking metabolic pathways
- Email: matthewlgoodwin@wustl.edu

Joseph Ippolito, MD, PhD
cancer, metabolism, imaging, sex differences, glioblastoma
- Email: ippolitoj@wustl.edu

Yoon-A Kang, PhD
Hematopoietic stem cells, Multipotent progenitor, Cell fate decision, Lineage specification
- Email: yoonakang@wustl.edu

Stephanie Markovina, MD, PhD
prognosis and response to radiation therapy, therapeutic targets for cervical and anal cancers
- Email: smarkovina@wustl.edu

Michael Meers, PhD
Epigenetics, Chromatin, Genomics, Gene Regulation, Cell fate, Transcription Factors
- Email: meers@wustl.edu

Gary Patti, PhD
To understand the metabolic crosstalk between cells and tissues in disease models such as cancer by using isotopes and metabolomics
- Email: gjpattij@wustl.edu

Guangyong Peng, PhD
Role of Senescent T cells in tumor and neurodegeneration; tumor-associated regulatory T cells (Tregs) in suppression of anti-tumor immunity, Toll-like receptor (TLR) ligands and other immunomodulators; metabolic and epigenetic reprogramming of T cells for immunotherapy
- Email: pengg@wustl.edu

Patrícia Ribeiro Pereira, PhD
Molecular imaging tools to understand tumor biology and response to therapies
- Email: ribeiropereirap@wustl.edu

Joshua B. Rubin, MD, PhD
tumor biology, signal transduction, stem cells, neural development, sexual dimorphism, circadaian rhythm, chemokines, cAMP
- Email: Rubin_J@wustl.edu

Julie Schwarz, MD, PhD
Gynecologic cancers, thyroid cancer, molecular imaging
- Email: jschwarz@wustl.edu

Girdhar Sharma, PhD
Epigenetics, stem cell radiation response, chromatin and DNA damage response, apoptosis, DNA repair, post-translational histone modifications, oncogenesis.
- Email: sharma@wustl.edu

Monica Shokeen, PhD
Antigen-4 (VLA-4) targeted PET radiopharmaceuticals, multiple myeloma, hematopoietic progenitor cells (HPCs), PET, MRI and Optical imaging techniques
- Email: mshokeen@wustl.edu

Jessica Silva-Fisher, PhD
Long non-coding RNAs and RNA modifications in cancer metastasis and relapse
- Email: silvajm@wustl.edu

Priyanka Verma, Ph.D.
The Verma lab studies the causes and consequences of DNA damage in cancers
- Email: vermap@wustl.edu

Zhongsheng You, PhD
Cancer, DNA damage response, RNA surveillance, cell cycle, chromatin, laser micro-irradiation, Xenopus egg extracts, imaging, genetically-encoded reporters
- Email: zyou@wustl.edu